Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 5 - The Real Truth

Nova Mentis Is Looking To Treat Autism With Psilocybin

Nova Mentis Life Science Corp. (OTCQB:NMLSF) and the private college Toronto Institute of Pharmaceutical Technology have signed a contract for the production of psilocybin capsules. The company will supply the microdose capsules for a Phase 2A fragile X syndrome (FXS) clinical study. FXS, also known as Martin-Bell syndrome, is one…

Canadian Cannabis Producers Are Financially Squeezed: Unpaid Marijuana Fees Grow 10X YoY To CA$914K

Canadian Cannabis Producers Are Financially Squeezed: Unpaid Marijuana Fees Grow 10X YoY To CA$914K

Has competition in the Canadian cannabis market finally reached its climax?

Hempsana Teams Up With GAMA To Launch New Cannabis Product Offerings And Brands

Hempsana Teams Up With GAMA To Launch New Cannabis Product Offerings And Brands

Hempsana Holdings Ltd. has entered into a contract manufacturing agreement with GAMA Corp to co-manufacture and distribute new products and brands from the United States to the Canadian and International Markets for both recreational and medicinal use.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD

Adastra Holdings Ltd. (OTCPK: XTXXF) (CSE: XTRX) (FRA: D2EP) recently completed the submission of its application for a controlled drugs and substances dealer's license. What Does It Mean?

Health Canada Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

Health Canada has approved Moderna Inc's (NASDAQ:MRNA) mRNA COVID-19 vaccine, Spikevax, two-dose series of 50 µg per dose to prevent COVID-19 in children aged six to11 years. The announcement follows the recent authorization of the Company's COVID-19 vaccine in the same age group in both Australia and the European Union. "Health Canada was…

Pure Extracts Exports First Shipment Of Cannabis Oil Extracts To German Pharma

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) has successfully exported its first batch of cannabis oil extracts to a German pharmaceutical company under a Health Canada export permit.

RYAH Medtech Secures Health Canada Medical Device License For Its Medical Cannabis Inhaler System

RYAH Medtech, Inc. subsidiary of RYAH Group, Inc. (CSE:RYAH) has received a Health Canada medical device license for its proprietary internet of things powered medical cannabis inhaler, proprietary cartridges and software application associated with the device.

inkl

Read news from The Economist, FT, and more,
with one subscription

Tetra Bio-Pharma Gets Health Canada's Approval To Use 100mg Of CBD In Inhaled Cannabidiol Safety Study

Tetra Bio-Pharma Gets Health Canada's Approval To Use 100mg Of CBD In Inhaled Cannabidiol Safety Study

Health Canada approved the amendment of a phase I study by Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB: TBPMF) (FRA: JAM1) conducted in collaboration with Dr.

Hempsana Holdings Receives Health Canada's Approval To Sell Medical Cannabis Directly To Patients Across Canada

Hempsana Holdings Receives Health Canada's Approval To Sell Medical Cannabis Directly To Patients Across Canada

Hempsana Holdings Ltd. has received its medical sales license from Health Canada which provides the company the ability to sell cannabis products directly to medical patients across Canada.

HYTN Innovations Receives Health Canada's Approval To Sell Cannabis

HYTN Innovations Receives Health Canada's Approval To Sell Cannabis

HYTN Innovations Inc.’s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.

Novavax's COVID-19 Vaccine Scores Canadian Approval

Novavax's COVID-19 Vaccine Scores Canadian Approval

Health Canada approves Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine in individuals 18 years of age and older.

Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants

Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants

Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants.

Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed

Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed

Health Canada approved Pfizer Inc's (NYSE: PFE) oral antiviral treatment for mild to moderate cases of COVID-19 in adults.

Blackhawk's MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder

Vancouver, British Columbia - TheNewswire - January 17, 2021 – Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the "Corporation" or "Blackhawk") is pleased to announce that its wholly-owned subsidiary MindBio Therapeutics Pty Ltd ("MindBio") is developing a new microdosing formula using LSD (Lysergic Acid Diethylamide) to treat Major Depressive Disorder…

Get all your
news in one place.

100's of premium titles.
One news app.

1 2 3 4 5

People

Stéphane Bancel

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Wikimedia Commons

Alnylam Pharmaceuticals

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

386,044 stories

British Columbia

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play